A SuperPowered CRO Joining Forces with Superpowered Clients
Together, we’re ready to save the world, one medical device or drug at a time. Come join us as the superhero saga continues…
We know your needs. We know the pitfalls of the submission process and how to avoid them. We’re here to make it happen— from concept to market.
You have an innovative medical device or drug, and you need an organization experienced in getting products approved and on the market.
Inc. 5000 Award
Proxima Clinical Research Ranks in the Top 25% of the Fastest Growing Private Companies in the USA
Proxima placed 1116 out of 5000 fast-growing companies in the U.S., and placed 105 among Texas based companies, 58 among health services companies, and 14 among Houston-based companies. According to Inc., this honor places Proxima CRO among top 0.07 percent of businesses in the nation.
FDA Issues Breakthrough Device Certification for Proxima Client Sigi™
Sigi™ provides a modern solution in the treatment of diabetes mellitus. It is the only insulin patch pump for closed loop integration designed for use with standard, pre-filled pump cartridges. Sigi™ can be programmed to deliver basal and bolus insulin at both set and variable rates via a Bluetooth-compatible continuous glucose monitors or alternative controller devices such as a smartphone or an iController.
From regulatory consulting to clinical research, Proxima is a full-service Contract Research Organization
Proxima works with emerging biotech and medical device companies across all phases of development. As a contract research organization, we organize our team in two distinct areas: early stage advisory consulting and all-inclusive clinical trial services. The service you need. The speed you want. The attention you deserve.
Developing medical technology for children has unique challenges. The Southwest National Pediatric Device Innovation Consortium (SWPDC) is a consortium that includes Baylor College of Medicine, Texas Children's Hospital, Texas A&M University, Rice University, University of Houston, and Fannin Innovation Studio. SWPDC is supported by an FDA grant to assist innovators with their pediatric device development as well as address their regulatory challenges. Proxima has been a strong partner for us in helping guide innovators quickly through their regulatory and clinical journey.
Chester J. Koh, MD
"Proxima staff understood the needs of our company and took a vested interest in supporting our clinical trial’s aggressive timeline while safeguarding our goals and objectives. Proxima has been a true partner for our early stage medical device startup!"
Sr. VP, Marketing & Clinical Development
I consider myself quite lucky that when I started as Director of Quality at our innovative SaMD start-up, we already were working with Proxima and Ellie Reynolds. It was invaluable to me to have a knowledgeable, collaborative and responsive partner in Ellie to help me build our QMS and to provide hands-on training in our eQMS, Greenlight Guru. Another great benefit of partnering with Proxima was that when extra help or expertise was required, Ellie always was quick to connect me with other resources on the Proxima team.